Cambridge, UK, – 17 December 2019: Abcam plc, a global innovator in life science reagents and tools, and SomaServe Ltd, a Pharma service and specialist reagent business exploiting PolyNautâ Technology, have announced a partnership to commercialise the cell delivery potential of the polymer-based ‘bionic’ nanoparticles, which can carry a range of payloads directly to live cells.
News
Westbury, NY – Dec. 16, 2019 – BioIVT, a leading provider of research models and services for drug and diagnostic development, today launched its Next-generation Sequencing (NGS) Service, which combines the company’s expertise in human tissue procurement, specimen selection, sample preparation and project management with its in-house NGS capabilities. BioIVT now offers both standard and custom NGS services, including sample extraction, library preparation, sequencing and bioinformatics.
The UK Innovation Corridor has a unique ecosystem of talent and commerce, with world-class businesses, universities and R&D centres standing firmly on a heritage of ground-breaking discovery and invention, as shown by a new report released today at the Genesis Conference by the London Stansted Cambridge Consortium.
This makes it the perfect place to start and build an innovation company and invest in place-making.
Start Codon cohort companies to receive One Nucleus membership benefits
CAMBRIDGE, UK, 11 December 2019 – Start Codon, a new model of life science and healthcare business accelerator, today announced it has partnered with One Nucleus, a membership organisation for life science and healthcare companies. Under the terms of the partnership agreement, One Nucleus will support and profile the life science and healthcare start-ups participating in the Start Codon accelerator programme.
Cambridge UK, 11 December 2019: Abcam has been honoured with a Glassdoor Employees’ Choice Award, recognising the Best Places to Work in 2020. Abcam is ranked 6th in Glassdoor’s Best Places to Work UK list.
The Employees’ Choice Awards are based solely on the input of employees who elect to provide feedback on their jobs, work environments and companies on Glassdoor, one of the world’s largest job and recruiting sites.
Events showcasing the latest products and innovations for lab professionals spans seven countries
Cambridge, UK, December 10 2019: Owlstone Medical, the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced it has joined the EU-funded Exposome Project for Health and Occupational Research (EPHOR). The consortium aims to further elucidate the complex relationships between environment and disease by developing the concept of the ‘working-life exposome’, which takes into account all occupational and related non-occupational exposures (e.g. lifestyle) throughout the lifespan of an individual.
AMSBIO reports on the pioneering research published** by scientists at Stanford University Medical School that has cited Mimetix® aligned 3D cell culture scaffold supplied by the company to understand the architecture of the myelin sheaths which insulate neuronal axons, so they can transmit electrical impulses quickly and efficiently.
ScreenIn3D, a partner of AMSBIO, has been awarded the prestigious ELRIG Prize for Innovation in Drug Discovery at their flagship conference Drug Discovery 2019 which recently took place in Liverpool, UK.
Cambridge, UK and Moscow, Russia, 09 December 2019: IONTAS Limited (IONTAS), a leader in the discovery and optimisation of fully human antibodies, has been informed that International Biotechnology Center (IBC) Generium, a leading Russian biopharmaceutical company, focused on developing and commercialising pharmaceutical products for the treatment of orphan diseases and cancer, has received approval from the Russian Health Authorities to initiate clinical trials with its CD3/CD19 bispecific antibody for the treatment of B-Cell Acute Lymphoblastic Leukemia (ALL).